Federal Register / Vol. 65, No. 84 / Monday, May 1, 2000 / Notices 25339

toll-free number (301) 435–0456 or Email your request, including your

address to: SorlieP@nih.gov.

Comments Due Date

Comments regarding this information

collection are best assured of having

their full effect it received on or before

June 30, 2000.

Dated: April 20, 2000.

Peter Savage,

Acting Director, Division of Epidemiology and

Clinical Applications, National Heart, Lung,

and Blood Institute.

[FR Doc. 00–10793 Filed 4–28–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Fogarty International Center; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Fogarty International Center Advisory

Board.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Fogarty International

Center Advisory Board.

Date: May 16, 2000.

Open: 8:30 a.m. to 12 p.m.

Agenda: Report of the Director, plans for

Fogarty International Center in-house

research activities, International

Epidemiology, Science Policy, and Putting

Mental Health on the International Agenda:

Role of the FIC and NIH.

Place: Lawton Chiles International House,

16 Center Drive, (Building 16), Bethesda, MD

20892.

Closed: 1 p.m. to adjournment.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Lawton Chiles International House,

16 Center Drive, (Building 16), Bethesda, MD

20892.

Contact Person: Irene W. Edwards,

Information Officer, Fogarty International

Center, National Institutes of Health,

Building 31, Room B2C08, 31 Center Drive

MSC 2220, Bethesda, MD 20892, 301–496–

2075.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.106, Minority International

Research Training Grant in the Biomedical

and Behavioral Sciences; 93.154, Special

International Postdoctoral Research Program

in Acquired Immunodeficiency Syndrome;

93.168, International Cooperative

Biodiversity Groups Program; 93.934, Fogarty

International Research Collaboration Award;

93.989, Senior International Fellowship

Awards Program, National Institutes of

Health, HHS)

Dated: April 21, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10786 Filed 4–28–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Eye Institute; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Board of Scientific Counselors, National

Eye Institute.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion and

evaluation of individual intramural

programs and projects conducted by the

National Eye Institute, including

consideration of personnel

qualifications and performance, and the

competence of individual investigators,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Board of Scientific

Counselors, National Eye Institute.

Date: June 5–6, 2000.

Open: June 5, 2000, 9 a.m. to 10 a.m.

Agenda: Opening remarks by the Director,

Intramural Research Program, on matters

concerning the intramural program of the

NEI.

Place: Building 10, Room 10B16, Bethesda,

MD 20892.

Closed: June 5, 2000, 10 a.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: Building 10, Room 10B16, Bethesda,

MD 20892.

Closed: June 6, 2000, 9 a.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: Building 10, Room 10B16, Bethesda,

MD 20892.

Contact Person: Robert B. Nussenblatt, MD,

Director, Intramural Research Program,

National Eye Institute, National Institutes of

Health, PHS, DHHS, Bethesda, MD 20892,

301–496–3123.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.867, Vision Research,

National Institutes of Health, HHS)

Dated: April 21, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10785 Filed 4–28–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: May 22, 2000.

Time: 8:30 a.m. to 4:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Ramada Inn Rockville, 1775

Rockville Pike, Rockville, MD 20852.

Contact Person: Aftab A. Ansari, Scientific

Review Administrator, National Institutes of